Stock Evaluator: Novanta Inc. (NOVT)

Novanta Inc. NOVT

$142.55 3.64 2.62%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 363,665
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Information Technology Electronic Equipment, Instruments & Components

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

Commentary & Analysis


Financial Summary

Share Statistics NOVT Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $5,382.9 $995.2 68%
Shares Out (Mil) 41.2 26.8 43%
Institutional Ownership 49.7% 85.0% 25%
Float (Mil) 37.5 37.5 41%
Beta 1.62 1.09 85%
Avg Daily Volume (000s) 393 254 55%
Price Change
(52-week)
15.7% 66.6% 58%
Growth NOVT Industry
Median
Percentile
(All Stocks)
Sales (5yr) 10.7% 4.8% 61%
Net Income (5yr) 3.9% 2.6% 45%
EPS (5yr) 3.3% 9.1% 35
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 41.0% (14.9%) 91%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 3 3 3
Current EPS $0.830 $3.590 $4.143
Month Ago EPS $0.830 $3.590 $4.143
# Rev Up 1 0 0
# Rev Down 2 3 1
Three Months Ago EPS $0.860 $3.563 $4.047
Year/Year Chg 62.7% 144.2% na
Financials NOVT Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1,005 $398 51%
Net Income (TTM) (Mil) $54 $4 56%
EPS (TTM) $1.425 $0.200 66%
Operating Cash Flow (TTM) (Mil) $84 $11 51%
Net Cash Flow (TTM) (Mil) $283 $3 87%
Long-Term Debt (Q1) (Mil) $240 $16 52%
Enterprise Value (Q1) (Mil) $5,572 $876 64%
Valuation NOVT Industry
Median
Percentile
(All Stocks)
P/B 3.87 2.56 72%
P/E 100.9 33.8 93%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 30.6 1.7 99%
Ratios NOVT Industry
Median
Percentile
(All Stocks)
Gross Margin 44.2% 33.0% 55%
Net Margin 5.3% 2.5% 49%
ROA 3.4% 2.0% 64%
ROE 5.2% 5.0% 44%
Liabilities to Assets 27.1% 40.6% 19%
F-Score 5 5 51%

Novanta Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors